{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:40:41Z","timestamp":1791463241381,"version":"4.3.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Infectopharm"},{"name":"Astellas"},{"DOI":"10.13039\/100007054","name":"MSD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MSD"},{"name":"Cardeas Pharma"},{"name":"Bayer"},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Basilea"},{"name":"Astra-Zeneca"},{"name":"Cubist-MSD"},{"name":"Kenta-Aridis"},{"DOI":"10.13039\/501100004628","name":"Medimmune","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004628","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Nektar Therapeutics"},{"name":"Bayer"},{"name":"Research Foundation of Stony Brook"},{"name":"Bayer"},{"name":"MSD"},{"name":"ThermoFisher Brahms"},{"name":"Astellas"},{"name":"European Study Group Critically Ill Patients (ESGCIP)"},{"name":"ESCMID Pharmacokinetics\/Pharmacodynamics Study Group (EPASG)"},{"DOI":"10.13039\/501100001704","name":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Basel, Switzerland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001704","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fundaci\u00f3 Catalana de Pneumonogia (FUCAP), Barcelona, Spain"},{"name":"Centro de Investigacion Biomedica en Red (CIBERES) (Programa Corporativo Integrado pneumonia), Madrid, Spain"},{"name":"Fondos Estructurales de Desarrollo Regional (FEDER)"},{"DOI":"10.13039\/501100000780","name":"European Commission, Brussels, Belgium","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.cmi.2017.04.011","type":"journal-article","created":{"date-parts":[[2017,4,13]],"date-time":"2017-04-13T12:15:41Z","timestamp":1492085741000},"page":"629-639","source":"Crossref","is-referenced-by-count":143,"title":["Use of nebulized antimicrobials for the treatment of respiratory infections in invasively mechanically ventilated adults: a position paper from the European Society of Clinical Microbiology and Infectious Diseases"],"prefix":"10.1016","volume":"23","author":[{"given":"J.","family":"Rello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Sol\u00e9-Lleonart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-J.","family":"Rouby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Chastre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Blot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Poulakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.-E.","family":"Luyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Riera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.B.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Felton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Dhanani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bassetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Welte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2017.04.011_bib1","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1164\/rccm.201207-1160OE","article-title":"Cystic fibrosis pulmonary guidelines","volume":"187","author":"Mogayzel","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2017.04.011_bib2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.cmi.2015.12.016","article-title":"Global survey on nebulization of antimicrobial agents in mechanically ventilated patients: a call for international guidelines","volume":"22","author":"Sol\u00e9-Lleonart","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2017.04.011_bib3","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.4187\/respcare.04519","article-title":"Intratracheal administration of antimicrobial agents in mechanically ventilated adults: an International Survey on Delivery Practices and Safety","volume":"61","author":"Sol\u00e9-Lleonart","year":"2016","journal-title":"Respir Care"},{"key":"10.1016\/j.cmi.2017.04.011_bib4","unstructured":"Sch\u00fcnemann H, Brozek J, Guyatt G, Oxman A (editors). Handbook for grading the quality of evidence and strength of recommendations using the GRADE approach [updated October 2013]. Available at: www.gradepro.org."},{"key":"10.1016\/j.cmi.2017.04.011_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2017.03.018","article-title":"Nebulisation of antimicrobial agents to mechanically ventilated patients: practical Recommendations for a safe and effective administration\u2014a Consensus Statement","author":"Rello","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2017.04.011_bib6","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2017.04.011_bib7","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/ALN.0000000000001570","article-title":"Nebulization of anti-infective agents in invasively mechanically ventilated adults: a systematic review and meta-analysis","volume":"126","author":"Sol\u00e9-Lleonart","year":"2017","journal-title":"Anaesthesiology"},{"key":"10.1016\/j.cmi.2017.04.011_bib8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00134-011-2420-0","article-title":"BAY41-6551 achieves bactericidal tracheal aspirate amikacin concentrations in mechanically ventilated patients with Gram-negative pneumonia","volume":"38","author":"Niederman","year":"2012","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cmi.2017.04.011_bib9","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1086\/657242","article-title":"Aerosolized plus intravenous clistin versus intravenous colistin alone for the treatment of ventilator-associated pneumonia: a matched case\u2013control study","volume":"51","author":"Kofteridis","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2017.04.011_bib10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2253-13-45","article-title":"Adjunctive aerosolized colistin for multi-drug resistant gram-negative pneumonia in the critically ill: a retrospective study","volume":"13","author":"Doshi","year":"2013","journal-title":"BMC Anesthesiol"},{"key":"10.1016\/j.cmi.2017.04.011_bib11","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1378\/chest.13-1018","article-title":"Effect of aerosolized colistin as adjunctive treatment on the outcomes of microbiologically documented ventilator-associated pneumonia caused by colistin-only susceptible gram-negative bacteria","volume":"144","author":"Tumbarello","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.cmi.2017.04.011_bib12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10096-008-0620-5","article-title":"Inhaled aminoglycosides in cancer patients with ventilator-associated Gram-negative bacterial pneumonia: safety and feasibility in the era of escalating drug resistance","volume":"28","author":"Ghannam","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2017.04.011_bib13","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1164\/rccm.201011-1894OC","article-title":"Nebulized ceftazidime and amikacin in ventilator-associated pneumonia caused by Pseudomonas aeruginosa","volume":"184","author":"Lu","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2017.04.011_bib14","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1097\/CCM.0b013e31817c0f9e","article-title":"Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit","volume":"36","author":"Palmer","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cmi.2017.04.011_bib15","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1164\/rccm.201312-2161OC","article-title":"Reduction of bacterial resistance with inhaled antibiotics in the Intensive Care Unit","volume":"189","author":"Palmer","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2017.04.011_bib16","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1093\/jac\/dkq360","article-title":"Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria","volume":"65","author":"Rattanaumpawan","year":"2010","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2017.04.011_bib17","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.4187\/respcare.01556","article-title":"Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia","volume":"57","author":"Arnold","year":"2012","journal-title":"Respir Care"},{"key":"10.1016\/j.cmi.2017.04.011_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1089\/sur.2006.051","article-title":"Aerosolized tobramycin in the treatment of ventilator-associated pneumonia: a pilot study","volume":"8","author":"Hallal","year":"2007","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.cmi.2017.04.011_bib19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13613-016-0127-7","article-title":"Efficacy and toxicity of aerosolized colistin in ventilator-associated pneumonia: a prospective, randomized trial","volume":"6","author":"Abdellatif","year":"2016","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.cmi.2017.04.011_bib20","series-title":"Cochrane Handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]","year":"2011"},{"key":"10.1016\/j.cmi.2017.04.011_bib21","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/phar.1309","article-title":"Aerosolized amphotericin B lipid complex as adjunctive treatment for fungal lung infection in patients with cancer-related immunosuppression and recipients of hematopoietic stem cell transplantation","volume":"33","author":"Safdar","year":"2013","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.cmi.2017.04.011_bib22","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1007\/s00134-008-1126-4","article-title":"Comparison of lung tissue concentrations of nebulized ceftazidime in ventilated piglets: ultrasonic versus vibrating plate nebulizers","volume":"34","author":"Ferrari","year":"2008","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cmi.2017.04.011_bib23","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00134-010-1879-4","article-title":"Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa","volume":"36","author":"Lu","year":"2010","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cmi.2017.04.011_bib24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1164\/ajrccm.165.2.2107025","article-title":"Lung tissue concentrations of nebulized amikacin during mechanical ventilation in piglets with healthy lungs","volume":"165","author":"Goldstein","year":"2002","journal-title":"Am J Resp Crit Care Med"},{"key":"10.1016\/j.cmi.2017.04.011_bib25","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1164\/rccm.200204-363OC","article-title":"Lung deposition and efficiency of nebulized amikacin during E.\u00a0coli pneumonia in ventilated piglets","volume":"166","author":"Goldstein","year":"2002","journal-title":"Am J Resp Crit Care Med"},{"key":"10.1016\/j.cmi.2017.04.011_bib26","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1097\/00000542-200304000-00033","article-title":"Lack of lung tissue and systemic accumulation after consecutive daily aerosols of amikacin in ventilated piglets with healthy lungs","volume":"98","author":"Ferrari","year":"2003","journal-title":"Anesthesiology"},{"key":"10.1016\/j.cmi.2017.04.011_bib27","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1097\/00000542-200207000-00028","article-title":"Influence of lung aeration on pulmonary concentrations of nebulized and intravenous amikacin in ventilated piglets with severe bronchopneumonia","volume":"97","author":"Elman","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1016\/j.cmi.2017.04.011_bib28","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1097\/00000542-200505000-00019","article-title":"Intravenous versus nebulized ceftazidime in ventilated piglets with and without experimental bronchopneumonia. Comparative effects of helium and nitrogen","volume":"102","author":"Tonnellier","year":"2005","journal-title":"Anesthesiology"},{"key":"10.1016\/j.cmi.2017.04.011_bib29","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1007\/s00134-009-1605-2","article-title":"Nebulized ceftazidime in experimental pneumonia caused by partially resistant Pseudomonas aeruginosa","volume":"35","author":"Ferrari","year":"2009","journal-title":"Intensive Care Med"},{"issue":"9","key":"10.1016\/j.cmi.2017.04.011_bib30","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cmi.2016.05.005","article-title":"Observational studies examining patients management in infectious diseases","volume":"23","author":"Paul","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2017.04.011_bib31","first-page":"187","article-title":"In\u00a0vitro assessment of a novel nebulizer for mechanically ventilated patients based on the eFlow \u00ae technology (abstract)","volume":"22","author":"Hahn","year":"2009","journal-title":"J\u00a0Aerosol Med Pulm Drug Deliv"},{"key":"10.1016\/j.cmi.2017.04.011_bib32","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1097\/ALN.0b013e3182755d7a","article-title":"Aerosolized antibiotics for ventilator-associated pneumonia","volume":"117","author":"Rouby","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1016\/j.cmi.2017.04.011_bib33","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/ALN.0b013e31827515de","article-title":"Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii","volume":"117","author":"Lu","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1016\/j.cmi.2017.04.011_bib34","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1056\/NEJMc071717","article-title":"Compounded colistimethate as possible cause of fatal acute respiratory distress syndrome","volume":"357","author":"McCoy","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2017.04.011_bib35","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.ijid.2010.08.001","article-title":"Hypersensitivity pneumonitis due to high-dose colistin aerosol therapy","volume":"14","author":"Leong","year":"2010","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.cmi.2017.04.011_bib36","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1378\/chest.101.4.1028","article-title":"Penetration of netilmicin in the lower respiratory tract after once-daily dosing","volume":"101","author":"Valcke","year":"1992","journal-title":"Chest"},{"key":"10.1016\/j.cmi.2017.04.011_bib37","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1378\/chest.128.2.545","article-title":"Penetration of gentamicin into the alveolar lining fluid of critically ill patients with ventilator-associated pneumonia","volume":"128","author":"Panidis","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.cmi.2017.04.011_bib38","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s00134-007-0688-x","article-title":"Reliability of mini-bronchoalveolar lavage for the measurement of epithelial lining fluid concentrations of tobramycin in critically ill patients","volume":"33","author":"Boselli","year":"2007","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cmi.2017.04.011_bib39","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1093\/clinids\/20.5.1217","article-title":"Ceftazidime monotherapy vs. ceftriaxone\/tobramycin for serious hospital-acquired gram negative infections. Antibiotic Study Group","volume":"20","author":"Rubinstein","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2017.04.011_bib40","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1097\/00003246-199710000-00015","article-title":"Empiric treatment of hospital-acquired respiratory tract infections with meropenem or ceftazidime with tobramycin: a randomized study. Meropenem Lower Respiratory Infection Group","volume":"25","author":"Sieger","year":"1997","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cmi.2017.04.011_bib41","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/bmj.38028.520995.63","article-title":"\u03b2 lactam monotherapy versus \u03b2 lactam-aminoglyco-side combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomized trials","volume":"328","author":"Paul","year":"2004","journal-title":"Brit Med J"},{"key":"10.1016\/j.cmi.2017.04.011_bib42","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1086\/430912","article-title":"Effect of aminoglycoside and \u03b2-lactam combination therapy versus \u03b2-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials","volume":"41","author":"Bliziotis","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.cmi.2017.04.011_bib43","article-title":"\u03b2 lactam antibiotic monotherapy versus \u03b2 lactam-aminoglycoside antibiotic combination therapy for sepsis","author":"Paul","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.cmi.2017.04.011_bib44","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01763-16","article-title":"Pharmacodynamics of aerosolized fosfomycin and amikacin against resistant clinical isolates of Pseudomonas aeruginosa and Klebsiella pneumonia in a hollow infection model: experimental basis for combination therapy","volume":"61","author":"Sime","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2017.04.011_bib45","article-title":"A\u00a0randomized trial of the amikacin fosfomycin inhalation system for the adjunctive therapy of Gram negative ventilator-associated pneumonia (IASIS Trial)","author":"Kollef","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.cmi.2017.04.011_bib46","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1183\/09031936.01.00220001","article-title":"European Respiratory Society guidelines on the use of nebulizers","volume":"18","author":"Boe","year":"2001","journal-title":"Eur Resp J"},{"key":"10.1016\/j.cmi.2017.04.011_bib47","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1592\/phco.30.6.562","article-title":"Consensus summary of aerosolized antimicrobial agents: application of guideline criteria, insights from the Society of Infectious Diseases Pharmacists","volume":"30","author":"Le","year":"2010","journal-title":"Pharmacotherapy"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X17302197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X17302197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T03:46:20Z","timestamp":1692762380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X17302197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S1198743X17302197"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2017.04.011","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]}}}